Erectile Dysfunction In Diabetes Is Not The End of Life
Innovations in gene therapy allowed American scientists to present a potentially new method to manage erectile dysfunction in diabetic patients.
It is known that diabetes is often followed by the development of erectile dysfunction and Viagra or its analogues fail to help these patients.
Scientists in genetic research from Colorado got positive results: they managed to restore erectile function in diabetic rats. It took a month to reach the result.
Erectile dysfunction as an adverse effect of diabetes occurs because of the damaged endothelium – a thin layer of cells that line the interior surface of blood vessels. Normally, endothelium generates nitric oxide that is responsible for relaxing smooth muscles of the vessels and supplying the penis with blood.
Viagra and its analogues do not let nitric oxide break down and provide an adequate erection. However, these drugs are useless for diabetic patients because endothelial cells do not function and do not generate nitric oxide.
During clinical studies, animals were injected with a VEGF medication (Vascular endothelial growth factor) to promote the growth of cells. In a month, the researchers got a result – erection in animals increased by 75%. Jesse Mills, a coordinator of the scientific and research project, claims that if this method will be recognized as safe, it will be available for all patients in the coming years.